Name: Global Veterinary Vaccines Market Size & Trends 2035
Creator: Roots Analysis
Published: 2026-08-18T00:00:01+05:30
License: https://www.rootsanalysis.com/privacy.html
Keywords: Veterinary Vaccines Market, Veterinary Vaccines Market Growth, Veterinary Vaccines Market Trends, Veterinary Vaccines Market Size, Veterinary Vaccines Market Share, Veterinary Vaccines Market Analysis, Veterinary Vaccines Market Forecast, Veterinary Vaccines Market Report, Global Veterinary Vaccines Market, Veterinary Vaccines Industry

Market Outlook

The global veterinary vaccines market, valued at USD 12.8 billion in 2025, is projected to reach USD 13.4 billion in 2026 and USD 22.0 billion by 2035, representing a CAGR of 5.69% during the forecast period 2026 to 2035.

Global Veterinary Vaccines Market Growth 2025 to 2035

See What’s in the Full Report – Request Your Complimentary Insights!

Market Report: Key Takeaways

Market Size & Trends

In terms of the type of targeted animal, the companion animal vaccine segment is anticipated to capture the largest share (60%) in the current market.
The parenteral route segment is estimated to capture majority of the market share, and this trend is unlikely to change in the future as well.
In terms of the technology, the inactivated vaccine segment is anticipated to capture the largest share (more than 50%) in the current market.

Veterinary Vaccines Market Share by Technology, 2035

In terms of the distribution channel, the veterinary hospitals and clinics segment occupies the highest share in the overall market.
North America captures the majority of the veterinary vaccines market share, and this trend is unlikely to change in the future as well.

Key Market Statistics

Market Size in 2026: $13.4 Billion
Estimated Market Size in 2035: $22.0 Billion
CAGR (2026-2035): 5.69%
North America: Largest market in 2026
Asia-Pacific: Fastest-growing region

Market Introduction

The global expenditure on veterinary healthcare has been increasing, driven by factors such as rising pet ownership, higher disposable incomes, and the growing willingness of pet owners to invest in their pets' well-being. As a result, the veterinary healthcare industry has witnessed significant growth worldwide.

Veterinary vaccines have evolved from an experimental endeavor to a routine and relatively safe practice in veterinary medicine. The primary objective of veterinary vaccines is to enhance companion animal health and to increase the cost-effective production of livestock. The use of veterinary vaccines is on the rise, with a significant impact on both animal health and public health. Vaccination is the most widely used tool in veterinary medicine to prevent and control animal diseases, representing the most cost-effective and sustainable method of managing infectious diseases. The field has seen successful applications of recombinant vaccines, with ongoing developments in rationally designed vaccine innovations to benefit animals, animal owners, and ultimately humans. Vaccination is considered the most effective way of preventing viral diseases in veterinary medicine, with attenuated and inactivated virus vaccines being the mainstay.

The increasing expenditure on pet health and veterinary services, along with the growing adoption of pet insurance, is expected to drive the utilization of routine vaccinations, presenting an opportunity for the players to capitalize on the rising demand for companion animal vaccines.

Market Segmentation

We have segmented the veterinary vaccines market into the type of targeted animal, route of administration, technology, distribution channel, and geography.

By Type of Targeted Animal

Companion Animal Vaccines, Livestock Animal Vaccines

By Route of Administration

Parenteral Routes, Oral Routes, Intranasal and Other Routes

By Vaccine Technology

Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Other Vaccines

By Distribution Channel

Veterinary Hospitals and Clinics, Pharmacies, Mobile Veterinary Units

By Geographical Regions

North America: US, Canada
Europe: Germany, UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: Australia, China, India, Japan, Philippines, Rest of Asia-Pacific
Latin America: Argentina, Brazil, Mexico, Rest of Latin America
Middle East and Africa: Chad, Ethiopia, Nigeria, Rest of Middle East and Africa

Your Business is Unique – Why Shouldn’t Your Report Be?

Veterinary Vaccines Market Key Insights

What are the Key Drivers for Veterinary Vaccines Market Growth?

Rising Demand for Animal-based Food Products: The current rise in the global population is fueling an increase in the demand for animal-based products, such as eggs, milk, and meat. Increasing awareness related to the nutritional value and associated health benefits of animal-based food products has prompted various people to consciously prefer protein-rich food obtained from animals. Vaccination of animals is important to maintain their health, secure the food supply for humans, prevent the transmission of zoonotic diseases to humans, and control disease outbreaks.
Increasing Incidence of Zoonotic Diseases: Around 60% of the known infectious diseases are zoonotic in origin (transmitted from animals to humans), responsible for 2.5 billion disease cases and 2.7 million human deaths every year, across the globe. Vaccination of animals helps protect animals as well as human population.
Ongoing Technological Advancements: The market for veterinary vaccines is expanding owing to the innovations in vaccine technology, including DNA vaccines, mRNA vaccines, nanoparticle subunit vaccines and recombinant viral-vector vaccines. Artificial intelligence and big data analytics have revolutionized the vaccine development field by reducing the timeline of the production process, supporting scale-up initiatives, and decreasing production expenses. These developments enhance the effectiveness and safety of vaccines, thereby allowing the veterinary vaccines market to flourish in the coming future.

What are the Main Challenges for Market Growth?

Climate Change and Evolving Pathogen Threats: Increasing pollution in the environment has led to climate change and environmental modifications. As a result, the vectors and pathogens have evolved and gained resistance against the existing vaccines and medications. These pathogens have the potential to cause outbreaks of several emerging infectious diseases in animals. One of the major challenges for research scientists is to develop broad-spectrum vaccines that provide protection against the evolving pathogens.
Lack of Reporting and Adequate Surveillance: Appropriate surveillance and reporting of animal diseases is important for their early diagnosis, control and eradication. Developing countries (with large populations and poor economies) lack well-defined resources and infrastructure for livestock disease surveillance and monitoring. Various livestock farmers are reluctant to perform diagnostic tests due to their high costs, thus leading to late diagnosis and reporting of the disease outbreak. Lack of data also complicates the decisions about the areas where the vaccines are needed urgently, resulting in a hindrance to their large-scale use.
Shortage of Adequate Veterinary Services: Inadequate veterinary services impact the pace of preventive vaccination and early diagnosis of diseases, leading to disease outbreaks and loss of livestock. The shortage of veterinary professionals in both developed and developing countries results in less guidance being provided to animal owners regarding vaccination programs, thereby affecting the market.

Recent Developments in Veterinary Vaccines Market

In May 2026, Merck’s vaccine for chicken against bronchitis received approval from Chinese agriculture ministry.
In April 2026, EMA recommended the market authorization of first veterinary vaccine using RNA technology.
In February 2026, Onderstepoort Biological Products SOC raised a grant worth USD 34.81 million from the South African Department of Agriculture / National Treasury for the production of its foot-and-mouth disease (FMD) vaccine.
In February 2026, Vaccine and Infectious Disease Organization received a grant worth USD 1 million from the Canadian Institutes of Health Research.
In January 2026, HIPRA entered into an agreement with Elanco Animal Health to distribute aMPV vaccines in the US poultry market.

Methodology and Industry Experts Interviews

The findings in this report were developed through a structured methodology combining secondary research, proprietary databases and primary interviews. Secondary research included company disclosures, regulatory databases, clinical-trial registries, peer-reviewed publications, patent records, pricing and reimbursement sources, and relevant market-access information. The resulting assumptions were triangulated against product approvals, pipeline progress, sales trends, formulation mix, regional access conditions and stakeholder interviews. The market report includes transcripts of the following third-party discussions:

Co-Founder, Company, Uganda
CEO, Company, Canada
Director, Large Hospital, US
Professor, Large University, US
Secretary, Department of Animal Husbandry & Dairying, Government of India
Secretary of US Department of Agriculture
Marketing Manager, Mid-Sized Company, Spain; Director, Large Company, France; Director, Large Company, Germany and Veterinarian, Small Company, UK
Veterinarian, Small Company, UK; Partner, Small Company, UK; Cattle Veterinary Lead, Large Company, UK and Representative, Mid-Sized Company, UK
Veterinarian, Large Company, US
Independent Veterinarian
Head of Bioscience, Mid-Sized Council in the UK and Animal Health Science Oversight, Department in the UK

Commenting on this, Dr Marissa Rothenbaum (Director of Veterinary Field Programs, Banfield Pet Hospital), stated that, “vaccines are one of the most powerful tools in preventive care, and advances such as mRNA and multi-variant vaccine technologies are enabling the broader protection in animal health while strengthening disease prevention at the community level.”

Pay Only for What You Need – The Best Way to Optimize

Companion Animal Vaccines Dominate the Veterinary Vaccines Market

Companion animal vaccines currently occupy the highest share (60%) in the veterinary vaccines market and are likely to grow at a relatively higher CAGR (6.1%), during the forecast period. This is due to the increasing prevalence of zoonotic diseases, as well as the rise in expenditure by pet owners as preventive measures to avoid the deadly transmissions.

Parenteral Route Holds the Largest Market Share of Veterinary Vaccines Market

The parenteral route segment holds the highest share (82%) of the veterinary vaccines market, owing to the fact that injections remain the primary dependable method for veterinarians to ensure that individual companion and livestock animals receive exact therapeutic volumes without degradation in the digestive tract.

Inactivated Vaccines Dominate the Veterinary Vaccines Market

Inactivated vaccines currently capture the maximum share (more than 50%) of the overall market. The market for recombinant vaccines is likely to grow at a relatively higher CAGR (7.6%) during the forecast period. This can be attributed to the fact that inactivated vaccines remain the foundational choice for mass-immunization programs because they eliminate the risk of horizontal transmission between animals, making them highly preferred by livestock managers and companion animal owners.

Veterinary Hospitals and Clinics Hold the Largest Market Share in Veterinary Vaccines Market

Veterinary hospitals and clinics hold the highest share of the veterinary vaccines market (65%) due to the presence of established cold-chain storage infrastructure, and the ability to administer vaccines in controlled clinical settings, making these facilities the preferred channel for vaccine distribution and administration. The mobile veterinary units, though, are likely to grow at a relatively higher CAGR (7.2%), owing to their convenience and rural point-of-care accessibility.

Veterinary Vaccines Market Size by End-Users, 2026 and 2035

Market Regional Insights

North America Dominates the Veterinary Vaccines Market

North America is likely to capture the majority (41%) of the veterinary vaccines market share in 2026. This can be attributed to the fact that there are large number of vaccine providers based in North America, along with significant demand for veterinary vaccines within this region.
The market in Asia-Pacific is likely to grow at a relatively higher CAGR (7.1%) during the forecast period. This is attributed by initiatives launched by governments, such as Indonesia’s agriculture ministry aims to distribute four million doses of foot-and-mouth disease (FMD) vaccine nationwide in 2026.

Get an Instant Quote in 10 Minutes. Lowest Price Guaranteed

Scope of Veterinary Vaccines Market Report

Key Report Attributes	Details
Key Players	Boehringer Ingelheim, Ceva Santé Animale, Elanco Animal Health, Haid Group, MSD Animal Health, Tecon Biology, Virbac, and Zoetis
Segments Covered	Type of Targeted Animal, Route of Administration, Vaccine Technology, Distribution Channels, and Geographical Regions
Excel Data Packs (Complimentary)	Veterinary Vaccines Landscape, Company Competitiveness Analysis, Partnerships and Collaborations, Funding and Investments, Global Event Analysis, Patent Analysis, and Market Forecast and Opportunity Analysis
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization

Report Authorship

This report was co-authored by Simriti Gupta and Nancy Kapila, members of the Roots Analysis healthcare and pharmaceutical research practice. Their work focuses on drug discovery and development, therapeutic-market assessment, competitive intelligence, clinical-pipeline analysis and market forecasting.

Independence and Non-Affiliation

This report is an independent work of market research and analysis published by Roots Analysis. It is not affiliated with, sponsored by, endorsed by, or reviewed by Boehringer Ingelheim, Ceva Santé Animale, Haid Group, MSD Animal Health, Tecon Biology, Virbac, Zoetis or any other pharmaceutical company, drug brand, or regulatory body referenced within it. No content in this report should be construed as medical advice. Roots Analysis maintains its own proprietary primary research process, and does not receive compensation from any company profiled within the report, in exchange for inclusion or favorable characterization.

+ 1. PREFACE

1.1. Introduction

1.2. Market Share Insights

1.3. Key Market Insights

1.4. Report Coverage

1.5. Key Questions Answered

+ 2. RESEARCH METHODOLOGY

2.1. Chapter Overview

2.2. Research Assumptions

2.2.1. Market Landscape and Market Trends

2.2.2. Market Forecast and Opportunity Analysis

2.2.3. Comparative Analysis

2.3. Database Building

2.3.1. Data Collection

2.3.2. Data Validation

2.3.3. Data Analysis

2.4. Project Methodology

2.4.1. Secondary Research

2.4.1.1. Annual Reports

2.4.1.2. Academic Research Papers

2.4.1.3. Company Websites

2.4.1.4. Investor Presentations

2.4.1.5. Regulatory Filings

2.4.1.6. White Papers

2.4.1.7. Industry Publications

2.4.1.8. Conferences and Seminars

2.4.1.9. Government Portals

2.4.1.10. Media and Press Releases

2.4.1.11. Newsletters

2.4.1.12. Industry Databases

2.4.1.13. Roots Proprietary Databases

2.4.1.14. Paid Databases and Sources

2.4.1.15. Social Media Portals

2.4.1.16. Other Secondary Sources

2.4.2. Primary Research

2.4.2.1. Types of Primary Research

2.4.2.1.1. Qualitative Research

2.4.2.1.2. Quantitative Research

2.4.2.1.3. Hybrid Approach

2.4.2.2. Advantages of Primary Research

2.4.2.3. Techniques for Primary Research

2.4.2.3.1. Interviews

2.4.2.3.2. Surveys

2.4.2.3.3. Focus Groups

2.4.2.3.4. Observational Research

2.4.2.3.5. Social Media Interactions

2.4.2.4. Key Opinion Leaders Considered in Primary Research

2.4.2.4.1. Company Executives (CXOs)

2.4.2.4.2. Board of Directors

2.4.2.4.3. Company Presidents and Vice Presidents

2.4.2.4.4. Research and Development Heads

2.4.2.4.5. Technical Experts

2.4.2.4.6. Subject Matter Experts

2.4.2.4.7. Scientists

2.4.2.4.8. Doctors and Other Healthcare Providers

2.4.2.5. Ethics and Integrity

2.4.2.5.1. Research Ethics

2.4.2.5.2. Data Integrity

2.4.3. Analytical Tools and Databases

2.5. Robust Quality Control

+ 3. MARKET DYNAMICS

3.1. Chapter Overview

3.2. Forecast Methodology

3.2.1. Top-down Approach

3.2.2. Bottom-up Approach

3.2.3. Hybrid Approach

3.3. Market Assessment Framework

3.3.1. Total Addressable Market (TAM)

3.3.2. Serviceable Addressable Market (SAM)

3.3.3. Serviceable Obtainable Market (SOM)

3.3.4. Currently Acquired Market (CAM)

3.4. Forecasting Tools and Techniques

3.4.1. Qualitative Forecasting

3.4.2. Correlation

3.4.3. Regression

3.4.4. Extrapolation

3.4.5. Convergence

3.4.6. Sensitivity Analysis

3.4.7. Scenario Planning

3.4.8. Data Visualization

3.4.9. Time Series Analysis

3.4.10. Forecast Error Analysis

3.5. Key Considerations

3.5.1. Demographics

3.5.2. Government Regulations

3.5.3. Reimbursement Scenarios

3.5.4. Market Access

3.5.5. Supply Chain

3.5.6. Industry Consolidation

3.5.7. Pandemic / Unforeseen Disruptions Impact

3.6. Limitations

+ 4. MACRO-ECONOMIC INDICATORS

4.1. Chapter Overview

4.2. Market Dynamics

4.2.1. Time Period

4.2.1.1. Historical Trends

4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage

4.2.2.1. Major Currencies Affecting the Market

4.2.2.2. Factors Affecting Currency Fluctuations

4.2.2.3. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Currency Exchange Rate

4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market

4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession

4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt

4.2.5. Inflation

4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy

4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates

4.2.6.1. Interest Rates and Their Impact on the Market

4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis

4.2.7.1. Type of Commodity

4.2.7.2. Origins and Destinations

4.2.7.3. Values and Weights

4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics

4.2.8.1. Import Scenario

4.2.8.2. Export Scenario

4.2.8.3. Trade Policies

4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers

4.2.8.5. Impact of Trade Barriers on the Market

4.2.9. War Impact Analysis

4.2.9.1. Russian-Ukraine War

4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors

4.2.10.1. Global Economic Impact

4.2.10.2. Industry-specific Impact

4.2.10.3. Government Response and Stimulus Measures

4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators

4.2.11.1. Fiscal Policy

4.2.11.2. Consumer Spending

4.2.11.3. Gross Domestic Product

4.2.11.4. Employment

4.2.11.5. Taxes

4.2.11.6. Stock Market Performance

4.2.11.7. Cross Border Dynamics

4.3. Conclusion

+ 5. EXECUTIVE SUMMARY

5.1. Executive Summary: Market Landscape

5.2. Executive Summary: Market Trends

5.3. Executive Summary: Market Forecast and Opportunity Analysis

+ 6. INTRODUCTION

6.1. Chapter Overview

6.2. Introduction to Veterinary Vaccines

6.3. Classification of Veterinary Vaccines

6.3.1. Classification based on Active Ingredient

6.3.1.1. Live, Attenuated Vaccines

6.3.1.2. Inactivated Vaccines

6.3.1.3. Toxoid Vaccines

6.3.1.4. Subunit Vaccines

6.3.1.5. Conjugate Vaccines

6.3.1.6. Viral Vector Vaccines

6.3.1.7. RNA Vaccines

6.3.1.8. DNA Vaccines

6.3.1.9. Recombinant Vaccines

6.3.2. Classification based on Type of Animal

6.3.2.1. Vaccines for Livestock Animals

6.3.2.2. Vaccines for Companion Animals

6.4. Advantages of Veterinary Vaccines

6.5. Historical Milestones: Vaccines against Common Animal Diseases

6.6. Future Perspective

+ 7. VETERINARY VACCINES MARKET: MARKET LANDSCAPE

7.1. Chapter Overview

7.2. Veterinary Vaccine Developers: Overall Market Landscape

7.2.1. Analysis by Year of Establishment

7.2.2. Analysis by Company Size

7.2.3. Analysis by Location of Headquarters

7.2.4. Analysis by Most Active Players

7.2.5. Analysis by Type of Company

7.2.6. Analysis by Stage of Development

7.2.7. Analysis by Type of Vaccine Technology

7.2.8. Analysis by Type of Target Animal

7.2.9. Analysis by Type of Companion Vaccine

7.2.10. Analysis by Type of Livestock Vaccine

+ 8. COMPANY COMPETITIVENESS ANALYSIS

8.1. Chapter Overview

8.2. Assumptions and Key Parameters

8.3. Methodology

8.4. Overview of Peer Groups

8.4.1. Peer Group I: Overview of Veterinary Vaccine Developers Based in North America

8.4.2. Peer Group II: Overview of Veterinary Vaccine Developers Based in Europe

8.4.3. Peer Group III: Overview of Veterinary Vaccine Developers Based in Asia-Pacific

8.4.4. Peer Group IV: Overview of Veterinary Vaccine Developers Based in Latin America

8.4.5. Peer Group V: Overview of Veterinary Vaccine Developers Based in Middle East and Africa

8.5. Veterinary Vaccine Developers: Company Competitiveness Analysis

8.5.1. Veterinary Vaccine Developers Based in North America (Peer Group I)

8.5.2. Veterinary Vaccine Developers Based in Europe (Peer Group II)

8.5.3. Veterinary Vaccine Developers Based in Asia-Pacific (Peer Group III)

8.5.4. Veterinary Vaccine Developers Based in Latin America (Peer Group IV)

8.5.5. Veterinary Vaccine Developers Based in Middle East and Africa (Peer Group V)

+ 9. COMPANY PROFILES

9.1. Chapter Overview

9.2. Boehringer Ingelheim

9.2.1. Company Overview

9.2.2. Veterinary Vaccine Portfolio

9.2.3. Recent Developments and Future Outlook

9.3. Ceva Santé Animale

9.3.1. Company Overview

9.3.2. Veterinary Vaccine Portfolio

9.3.3. Recent Developments and Future Outlook

9.4. Elanco Animal Health

9.4.1. Company Overview

9.4.2. Veterinary Vaccine Portfolio

9.4.3. Recent Developments and Future Outlook

9.5. Haid Group

9.5.1. Company Overview

9.5.2. Veterinary Vaccine Portfolio

9.5.3. Recent Developments and Future Outlook

9.6. MSD Animal Health

9.6.1. Company Overview

9.6.2. Veterinary Vaccine Portfolio

9.6.3. Recent Developments and Future Outlook

9.7 Tecon Biology

9.7.1. Company Overview

9.7.2. Veterinary Vaccine Portfolio

9.7.3. Recent Developments and Future Outlook

9.8. Virbac

9.8.1. Company Overview

9.8.2. Veterinary Vaccine Portfolio

9.8.3. Recent Developments and Future Outlook

9.9. Zoetis

9.9.1. Company Overview

9.9.2. Veterinary Vaccine Portfolio

9.9.3. Recent Developments and Future Outlook

+ 10. PARTNERSHIPS AND COLLABORATIONS

10.1. Chapter Overview

10.2. Partnership Models

10.3. Veterinary Vaccine Developers: Partnerships and Collaborations

10.3.1. Analysis by Year of Partnership

10.3.2. Analysis by Type of Partnership

10.3.3. Analysis by Year and Type of Partnership

10.3.4. Analysis by Type of Partner

10.3.5. Analysis by Type of Partnership and Type of Partner

10.3.6. Most Active Players: Analysis by Number of Partnerships

10.4. Analysis by Geography

10.4.1. Local and International Agreements

10.4.2. Intracontinental and Intercontinental Agreements

+ 11. FUNDING AND INVESTMENT ANALYSIS

11.1. Chapter Overview

11.2. Funding Models

11.3. Veterinary Vaccines Market: Funding and Investment Analysis

11.3.1. Analysis by Year of Funding

11.3.1.1. Cumulative Year-wise Trend of Funding Instances

11.3.1.2. Cumulative Year-wise Trend of Amount Invested

11.3.2. Analysis by Type of Funding

11.3.2.1. Analysis of Funding Instances

11.3.2.2. Analysis of Amount Invested

11.3.3. Analysis by Year and Type of Funding

11.3.4. Analysis of Amount Invested by Year and Type of Funding

11.3.5. Analysis by Geography

11.3.6. Most Active Players

11.3.6.1. Analysis by Number of Funding Instances

11.3.6.2. Analysis by Amount Raised

11.3.6.3. Leading Investors: Analysis by Number of Funding Instances

+ 12. GLOBAL EVENT ANALYSIS

12.1. Chapter Overview

12.2. Scope and Methodology

12.3. Veterinary Vaccines Market: Global Event Analysis

12.3.1. Analysis by Year of Event

12.3.2. Analysis by Event Platform

12.3.3. Analysis by Geography

12.3.4. Analysis by Type of Event

12.3.5. Most Active Event Organizers

+ 13. PATENT ANALYSIS

13.1. Chapter Overview

13.2. Scope and Methodology

13.3. Veterinary Vaccines Market: Patent Analysis

13.3.1. Analysis by Patent Publication Year

13.3.2. Analysis by Type of Patent and Publication Year

13.3.3. Analysis by Patent Application Year

13.3.4. Analysis by Patent Jurisdiction

13.3.5. Analysis by CPC Symbols

13.3.6. Analysis by Type of Applicant

13.3.7. Leading Industry Players: Analysis by Number of Patents

13.3.8. Leading Non-Industry Players: Analysis by Number of Patents

13.3.9. Leading Individual Assignees: Analysis by Number of Patents

13.4. Patent Benchmarking Analysis

13.4.1. Analysis by Patent Characteristics

13.5. Patent Valuation

+ 14. MEGA TRENDS

14.1. Chapter Overview

14.2. Veterinary Vaccines: Key Megatrends

+ 15. MARKET IMPACT ANALYSIS:

15.1. Chapter Overview

15.2. Market Drivers

15.3. Market Restraints

15.4. Market Opportunities

15.5. Market Challenges

15.6. Conclusion

+ 16. GLOBAL VETERINARY VACCINES MARKET

16.1. Chapter Overview

16.2. Key Assumptions and Methodology

16.3. Global Veterinary Vaccines Market, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

16.3.1. Scenario Analysis

16.3.1.1. Conservative Scenario

16.3.1.2. Optimistic Scenario

16.4. Key Market Segmentation

+ 17. VETERINARY VACCINES MARKET, BY TYPE OF TARGETED ANIMAL

17.1. Chapter Overview

17.2. Key Assumptions and Methodology

17.2.1. Veterinary Vaccines Market: Distribution by Type of Targeted Animal

17.2.2. Veterinary Vaccines Market for Companion Animal Vaccines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

17.2.3. Veterinary Vaccines Market for Livestock Animal Vaccines, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

17.3. Data Triangulation and Validation

+ 18. VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION

18.1. Chapter Overview

18.2. Key Assumptions and Methodology

18.2.1. Veterinary Vaccines Market: Distribution by Route of Administration

18.2.2. Veterinary Vaccines Market for Parenteral Route: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.2.3. Veterinary Vaccines Market for Oral Route, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.2.4. Veterinary Vaccines Market for Intranasal and Other Route: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

+ 19. VETERINARY VACCINES MARKET, BY TYPE OF VACCINE TECHNOLOGY

19.1. Chapter Overview

19.2. Key Assumptions and Methodology

19.2.1. Veterinary Vaccines Market: Distribution by Type of Vaccine Technology

19.2.2. Veterinary Vaccines Market for Live Attenuated Vaccines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

19.2.3. Veterinary Vaccines Market for Inactivated Vaccines, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

19.2.4. Veterinary Vaccines Market for Recombinant Vaccines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

19.2.5. Veterinary Vaccines Market for Others: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

19.3. Data Triangulation and Validation

+ 20. VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL

20.1. Chapter Overview

20.2. Key Assumptions and Methodology

20.2.1. Veterinary Vaccines Market: Distribution by Distribution Channel

20.2.2. Veterinary Vaccines Market for Veterinary Hospitals and Clinics: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

20.2.3. Veterinary Vaccines Market for Pharmacies, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

20.2.4. Veterinary Vaccines Market for Mobile Veterinary Units, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

20.3. Data Triangulation and Validation

+ 21. VETERINARY VACCINES MARKET, BY GEOGRAPHICAL REGIONS

21.1. Chapter Overview

21.2. Key Assumptions and Methodology

21.2.1. Veterinary Vaccines Market: Distribution by Geographical Regions

21.2.2. Veterinary Vaccines Market in North America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.2.1. Veterinary Vaccines Market in the US, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.2.2. Veterinary Vaccines Market in Canada, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.3. Veterinary Vaccines Market in Europe: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.3.1. Veterinary Vaccines Market in Germany: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.3.2. Veterinary Vaccines Market in the UK: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.3.3. Veterinary Vaccines Market in France: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.3.4. Veterinary Vaccines Market in Spain: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.3.5. Veterinary Vaccines Market in Italy: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.3.6. Veterinary Vaccines Market in Rest of Europe: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.4. Veterinary Vaccines Market in Asia-Pacific: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.4.1. Veterinary Vaccines Market in Australia: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.4.2. Veterinary Vaccines Market in China: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.4.3. Veterinary Vaccines Market in India: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.4.4. Veterinary Vaccines Market in Japan: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.4.5. Veterinary Vaccines Market in Philippines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.4.6. Veterinary Vaccines Market in Rest of Asia-Pacific: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.5. Veterinary Vaccines Market in Latin America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.5.1. Veterinary Vaccines Market in Argentina: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.5.2. Veterinary Vaccines Market in Brazil: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.5.3. Veterinary Vaccines Market in Mexico: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.5.4. Veterinary Vaccines Market in Rest of Latin America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.6. Veterinary Vaccines Market in Middle East and Africa: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.6.1. Veterinary Vaccines Market in Chad: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.6.2. Veterinary Vaccines Market in Ethiopia: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.6.3. Veterinary Vaccines Market in Nigeria: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

21.2.6.4. Veterinary Vaccines Market in Rest of Middle East and Africa: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

+ 22. CONCLUSION

22.1. Chapter Overview

+ 23. EXECUTIVE INSIGHTS

23.1. Chapter Overview

23.2. Company A

23.2.1. Company Snapshot

23.2.2. Interview Transcript: Co-Founder

23.3. Company B

23.3.1. Company Snapshot

23.3.2. Interview Transcript: CEO

23.4. Company C

23.4.1. Company Snapshot

23.4.2. Interview Transcript: Director

23.5. Company D

23.5.1. Company Snapshot

23.5.2. Interview Transcript: Professor

23.6. Company E

23.6.1. Company Snapshot

23.6.2. Interview Transcript: Secretary

23.7. Company F

23.7.1. Company Snapshot

23.7.2. Interview Transcript: Secretary

23.8. Company G

23.8.1. Company Snapshot

23.8.2. Interview Transcript: Marketing Manager, Director, Director and Veterinarian

23.9. Company H

23.9.1. Company Snapshot

23.9.2. Interview Transcript: Veterinarian, Partner, Cattle Veterinary Lead and Representative

23.10. Company I

23.10.1. Company Snapshot

23.10.2. Interview Transcript: Veterinarian

23.11. Company J

23.11.1. Company Snapshot

23.11.2. Interview Transcript: Independent Veterinarian

23.12. Company K

23.12.1. Company Snapshot

23.12.2. Interview Transcript: Head of Bioscience and Animal Health Science Oversight

+ 24. APPENDIX I: TABULATED DATA

+ 25. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

+ List of Figures

Figure 2.1 Research Methodology: Project Methodology

Figure 2.2 Research Methodology: Data Sources for Secondary Research

Figure 2.3 Research Methodology: Robust Quality Control

Figure 3.1 Market Dynamics: Forecast Methodology

Figure 3.2 Market Dynamics: Market Assessment Framework

Figure 4.1 Lessons Learnt from Past Recessions

Figure 5.1 Executive Summary: Market Landscape

Figure 5.2 Executive Summary: Recent Trends (I/II)

Figure 5.3 Executive Summary: Recent Trends (II/II)

Figure 5.4 Executive Summary: Market Sizing and Opportunity Analysis

Figure 6.1 Classification of Veterinary Vaccines based on Active Ingredient

Figure 6.2 Classification of Vaccines based on Type of Animal

Figure 7.1 Veterinary Vaccines Developers: Distribution by Year of Establishment

Figure 7.2 Veterinary Vaccines Developers: Distribution by Company Size

Figure 7.3 Veterinary Vaccines Developers: Distribution by Location of Headquarters

Figure 7.4 Most Active Players: Distribution by Number of Veterinary Vaccines Developed

Figure 7.5 Veterinary Vaccine Developers: Distribution by Type of Company

Figure 7.6 Veterinary Vaccines Developers: Distribution by Stage of Development

Figure 7.7 Veterinary Vaccines Developers: Distribution by Type of Vaccine Technology

Figure 7.8 Veterinary Vaccine Developers: Distribution by Type of Target Animal

Figure 7.9 Veterinary Vaccine Developers: Distribution by Type of Companion Vaccine

Figure 7.10 Veterinary Vaccine Developers: Distribution by Type of Livestock Vaccine

Figure 8.1 Company Competitiveness Analysis: Veterinary Vaccine Developers Based in North America (Peer Group I)

Figure 8.2 Company Competitiveness Analysis: Overview of Veterinary Vaccine Developers Based in Europe (Peer Group II)

Figure 8.3 Company Competitiveness Analysis: Overview of Veterinary Vaccine Developers based in Asia-Pacific (Peer Group III)

Figure 8.4 Company Competitiveness Analysis: Overview of Veterinary Vaccine Developers based in Latin America (Peer Group IV)

Figure 8.5 Company Competitiveness Analysis: Overview of Veterinary Vaccine Developers based in Middle East and Africa (Peer Group V)

Figure 8.6 Company Competitiveness Analysis: Veterinary Vaccine Developers Based in North America

Figure 8.7 Company Competitiveness Analysis: Veterinary Vaccine Developers Based in Europe

Figure 8.8 Company Competitiveness Analysis: Veterinary Vaccine Developers Based in Asia-Pacific

Figure 8.9 Company Competitiveness Analysis: Veterinary Vaccine Developers Based in Latin America

Figure 8.10 Company Competitiveness Analysis: Veterinary Vaccine Developers Based in Middle East and Africa

Figure 10.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2022

Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership

Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2022

Figure 10.4 Partnerships and Collaborations: Distribution by Type of Partner

Figure 10.5 Partnerships and Collaborations: Distribution by Type of Partner and Type of Partnership

Figure 10.6 Most Active Players: Distribution by Number of Partnerships

Figure 10.7 Partnerships and Collaborations: Local and International Agreements

Figure 10.8 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements

Figure 11.1 Funding and Investment Analysis: Cumulative Year-wise Trend, Since 2022

Figure 11.2 Funding and Investment Analysis: Cumulative Year-wise Trend of Amount Invested, Since 2022 (USD Million)

Figure 11.3 Funding and Investment Analysis: Distribution of Funding Instances by Type of Funding

Figure 11.4 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)

Figure 11.5 Funding and Investment Analysis: Distribution by Year and Type of Funding, Since 2022

Figure 11.6 Funding and Investment Analysis: Distribution of Amount Invested by Year and Type of Funding

Figure 11.7 Funding and Investment Analysis: Distribution by Geography

Figure 11.8 Most Active Players: Distribution by Number of Funding Instances

Figure 11.9 Most Active Players: Distribution by Amount Raised

Figure 11.10 Leading Investors: Distribution by Number of Funding Instances

Figure 12.1 Global Event Analysis: Cumulative Half year-wise Trend, Since 2023

Figure 12.2 Global Event Analysis: Distribution by Event Platform

Figure 12.3 Global Event Analysis: Distribution by Geography

Figure 12.4 Global Event Analysis: Distribution by Type of Event

Figure 12.5 Most Active Event Organizers: Distribution by Number of Events

Figure 13.1 Patent Analysis: Distribution by Type of Patent

Figure 13.2 Patent Analysis: Cumulative Year-wise Trend by Publication Year, Since 2020

Figure 13.3 Patent Analysis: Distribution by Type of Patent and Publication Year, Since 2020

Figure 13.4 Patent Analysis: Distribution by Patent Application Year, Since 2010

Figure 13.5 Patent Analysis: Distribution by Patent Jurisdiction

Figure 13.6 Patent Analysis: Distribution by CPC Symbols

Figure 13.7 Patent Analysis: Distribution by Type of Applicant, Since 2020

Figure 13.8 Leading Industry Players: Distribution by Number of Patents

Figure 13.9 Leading Non-Industry Players: Distribution by Number of Patents

Figure 13.10 Leading Individual Assignees: Distribution by Number of Patents

Figure 13.11 Patent Benchmarking Analysis: Distribution of Patent Characteristics (CPC Codes) by Leading Industry Players

Figure 13.12 Patent Benchmarking Analysis: Distribution of Leading Industry Players by Patent Characteristics (CPC Codes)

Figure 13.13 Patent Analysis: Distribution by Patent Age

Figure 13.14 Veterinary Vaccines: Patent Valuation

Figure 14.1 Veterinary Vaccines: Key Megatrends

Figure 16.1 Global Veterinary Vaccines Market, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 16.2 Global Veterinary Vaccines Market, Forecasted Estimates (Till 2035), Conservative Scenario (USD Billion)

Figure 16.3 Global Veterinary Vaccines Market, Forecasted Estimates (Till 2035), Optimistic Scenario (USD Billion)

Figure 17.1 Veterinary Vaccines Market: Distribution by Type of Targeted Animal

Figure 17.2 Veterinary Vaccines Market for Companion Animal Vaccine: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 17.3 Veterinary Vaccines Market for Livestock Animal Vaccine, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 18.1 Veterinary Vaccines Market: Distribution by Route of Administration

Figure 18.2 Veterinary Vaccines Market for Parenteral Route: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 18.3 Veterinary Vaccines Market for Oral Route, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 18.4 Veterinary Vaccines Market for Intranasal and other routes: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 19.1 Veterinary Vaccines Market: Distribution by Type of Vaccine Technology

Figure 19.2 Veterinary Vaccines Market for Live Attenuated Vaccines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 19.3 Veterinary Vaccines Market for Inactivated Vaccines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 19.4 Veterinary Vaccines Market for Recombinant Vaccines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 19.5 Veterinary Vaccines Market for Others: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 20.1 Veterinary Vaccines Market: Distribution by Distribution Channel

Figure 20.2 Veterinary Vaccines Market for Veterinary Hospitals and Clinics: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 20.3 Veterinary Vaccines Market for Pharmacies, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 20.4 Veterinary Vaccines Market for Mobile Veterinary Units, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.1 Veterinary Vaccines Market: Distribution by Geographical Regions

Figure 21.2 Veterinary Vaccines Market in North America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.3 Veterinary Vaccines Market in the US, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.4 Veterinary Vaccines Market in Canada, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.5 Veterinary Vaccines Market in Europe: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.6 Veterinary Vaccines Market in Germany: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.7 Veterinary Vaccines Market in the UK: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.8 Veterinary Vaccines Market in France: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.9 Veterinary Vaccines Market in Spain: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.10 Veterinary Vaccines Market in Italy: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.11 Veterinary Vaccines Market in Rest of Europe: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.12 Veterinary Vaccines Market in Asia-Pacific: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.13 Veterinary Vaccines Market in Australia: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.14 Veterinary Vaccines Market in China: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.15 Veterinary Vaccines Market in India: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.16 Veterinary Vaccines Market in Japan: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.17 Veterinary Vaccines Market in Philippines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.18 Veterinary Vaccines Market in Rest of Asia-Pacific: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.19 Veterinary Vaccines Market in Latin America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.20 Veterinary Vaccines Market in Argentina: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.21 Veterinary Vaccines Market in Brazil: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.22 Veterinary Vaccines Market in Mexico: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.23 Veterinary Vaccines Market in Rest of Latin America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.24 Veterinary Vaccines Market in Middle East and Africa: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.25 Veterinary Vaccines Market in Chad: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.26 Veterinary Vaccines Market in Ethiopia: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.27 Veterinary Vaccines Market in Nigeria: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.28 Veterinary Vaccines Market in Rest of Middle East and Africa: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Figure 21.29 Market Movement Analysis: Geographical Regions

Figure 21.30 Penetration-Growth (P-G) Matrix: Geographical Regions

Figure 22.1 Concluding Remarks: Market Landscape

Figure 22.2 Concluding Remarks: Partnerships and Collaborations

Figure 22.3 Concluding Remarks: Funding and Investment Analysis

Figure 22.4 Concluding Remarks: Global Event Analysis

Figure 22.5 Concluding Remarks: Patent Analysis

Figure 22.6 Concluding Remarks: Market Forecast

+ List of Tables

Table 7.1 Veterinary Vaccine Developers: Information on Year of Establishment, Company Size and Location of Headquarters

Table 7.2 Veterinary Vaccine Developers: Information on Number of Veterinary Vaccines Developed and Type of Company

Table 7.3 Veterinary Vaccine Developers: Information on Stages of Development and Type of Vaccine Technology

Table 7.4 Veterinary Vaccines Developers: Information on Type of Target Animal and Type of Companion Vaccine

Table 7.5 Veterinary Vaccine Developers: Information on Type of Livestock Vaccine

Table 9.1 Veterinary Vaccine Developers: List of Companies Profiled

Table 9.2 Boehringer Ingelheim: Company Overview

Table 9.3 Boehringer Ingelheim: Veterinary Vaccine Portfolio

Table 9.4 Boehringer Ingelheim: Recent Developments and Future Outlook

Table 9.5 Ceva Santé Animale: Company Overview

Table 9.6 Ceva Santé Animale: Veterinary Vaccine Portfolio

Table 9.7 Ceva Santé Animale: Recent Developments and Future Outlook

Table 9.8 Elanco Animal Health: Company Overview

Table 9.9 Elanco Animal Health: Veterinary Vaccine Portfolio

Table 9.10 Elanco Animal Health: Recent Developments and Future Outlook

Table 9.11 Haid Group: Company Overview

Table 9.12 MSD Animal Health: Company Overview

Table 9.13 MSD Animal Health: Veterinary Vaccine Portfolio

Table 9.14 MSD Animal Health: Recent Developments and Future Outlook

Table 9.15 Tecon Biology: Company Overview

Table 9.16 Tecon Biology: Veterinary Vaccine Portfolio

Table 9.17 Tecon Biology: Recent Developments and Future Outlook

Table 9.18 Virbac: Company Overview

Table 9.19 Virbac: Veterinary Vaccine Portfolio

Table 9.20 Virbac: Recent Developments and Future Outlook

Table 9.21 Zoetis: Company Overview

Table 9.22 Zoetis: Veterinary Vaccine Portfolio

Table 9.23 Zoetis: Recent Developments and Future Outlook

Table 10.1 Veterinary Vaccines: List of Partnerships and Collaborations, Since 2022

Table 10.2 Veterinary Vaccines: List of Type of Agreement (Country), Type of Agreement (Continent)

Table 11.1 Veterinary Vaccines Market: List of Funding and Investments, Since 2022

Table 12.1 List of Global Events related to Veterinary Vaccines Market

Table 13.1 Patent Analysis: CPC Sections

Table 13.2 Patent Analysis: Top CPC Symbols

Table 13.3 Patent Analysis: Top CPC Codes

Table 13.4 Patent Analysis Categorization based on Weighted Valuation Scores

Table 13.5 Patent Analysis: Categorization based on Weighted Valuation Scores

Table 24.1 Veterinary Vaccine Developers: Distribution by Year of Establishment

Table 24.2 Veterinary Vaccine Developers: Distribution by Company Size

Table 24.3 Veterinary Vaccine Developers: Distribution by Location of Headquarters

Table 24.4 Veterinary Vaccine Developers: Distribution by Number of Vaccines Developed

Table 24.5 Veterinary Vaccine Developers: Distribution by Type of Company

Table 24.6 Veterinary Vaccine Developers: Stage of Development

Table 24.7 Veterinary Vaccine Developers: Distribution by Type of Vaccine Technology

Table 24.8 Veterinary Vaccine Developers: Distribution by Type of Target Animal

Table 24.9 Veterinary Vaccine Developers: Distribution by Type of Companion Vaccine

Table 24.10 Veterinary Vaccine Developers: Distribution by Type of Livestock Vaccine

Table 24.11 Partnerships and Collaborations: Cumulative Year-Wise Trend, Since Pre-2021

Table 24.12 Partnerships and Collaborations: Distribution by Type of Partnership

Table 24.13 Partnerships and Collaborations: Distribution by Year and Type of Partnership

Table 24.14 Partnerships and Collaborations: Distribution by Type of Partner

Table 24.15 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner

Table 24.16 Most Active Players: Distribution by Number of Partnerships

Table 24.17 Partnerships and Collaborations: Distribution by Local and International Agreements

Table 24.18 Partnerships and Collaborations: Distribution by Location of Headquarters of Parent Company (Country-wise) and Type of Agreement

Table 24.19 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements

Table 24.20 Funding and Investments Analysis: Distribution of Instances by Year of Funding

Table 24.21 Funding and Investments Analysis: Distribution of Amount by Year of Funding (USD Million)

Table 24.22 Funding and Investments Analysis: Distribution of Funding Instances by Type of Funding

Table 24.23 Funding and Investments Analysis: Distribution by Amount of Funding

Table 24.24 Funding and Investments Analysis: Distribution by Year and Type of Funding, Since 2022

Table 24.25 Funding and Investments Analysis: Distribution of Amount Invested by Year and Type of Funding (USD Million)

Table 24.26 Funding and Investments Analysis: Distribution by Geography

Table 24.27 Most Active Players: Distribution by Number of Funding Instances

Table 24.28 Most Active Players: Distribution by Amount Raised (USD Million)

Table 24.29 Leading Investors: Distribution by Number of Funding Instances

Table 24.30 Global Event Analysis: Cumulative Quarter-wise Trend, Since 2023

Table 24.31 Global Event Analysis: Distribution by Event Platform

Table 24.32 Global Event Analysis: Distribution by Geography

Table 24.33 Global Event Analysis: Distribution by Geography

Table 24.34 Most Active Event Organizers: Distribution by Number of Events

Table 24.35 Patent Analysis: Distribution by Type of Patent

Table 24.36 Patent Analysis: Cumulative Year-wise Trend by Application Year

Table 24.37 Patent Analysis: Cumulative Year-wise Trend by Publication Year

Table 24.38 Patent Analysis: Cumulative Year-wise Trend of Patent Applications by Publication Year

Table 24.39 Patent Analysis: Distribution by Patent Jurisdiction

Table 24.40 Patent Analysis: Distribution by Type of Applicant

Table 24.41 Most Active Industry Players: Distribution by Number of Patents

Table 24.42 Most Active Non-Industry Players: Distribution by Number of Patents

Table 24.43 Leading Individual Assignees: Distribution by Number of Patents

Table 24.44 Patent Analysis: Distribution by Patent Age

Table 24.45 Global Veterinary Vaccines Market, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.46 Veterinary Vaccines Market, Distribution by Type of Targeted Animal (USD Billion)

Table 24.47 Veterinary Vaccines Market for Companion Animal Vaccine: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.48 Veterinary Vaccines Market for Livestock Animal Vaccine: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.49 Veterinary Vaccines Market, Distribution by Route of Administration (USD Billion)

Table 24.50 Veterinary Vaccines Market for Parenteral Route: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.51 Veterinary Vaccines Market for Oral Route: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.52 Veterinary Vaccines Market for Intranasal and Other Routes: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.53 Veterinary Vaccines Market, Distribution by Type of Vaccine Technology (USD Billion)

Table 24.54 Veterinary Vaccines Market for Live Attenuated Vaccines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.55 Veterinary Vaccines Market for Inactivated Vaccines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.56 Veterinary Vaccines Market for Recombinant Vaccines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.57 Veterinary Vaccines Market for Others: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.58 Veterinary Vaccines Market, Distribution by Distribution Channel (USD Billion)

Table 24.59 Veterinary Vaccines Market for Veterinary Hospitals and Clinics: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.60 Veterinary Vaccines Market for Pharmacies: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.61 Veterinary Vaccines Market for Mobile Veterinary Units: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.62 Veterinary Vaccines Market, Distribution by Geography (USD Billion)

Table 24.63 Veterinary Vaccines Market in North America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.64 Veterinary Vaccines Market in US: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.65 Veterinary Vaccines Market in Canada: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.66 Veterinary Vaccines Market in Europe: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.67 Veterinary Vaccines Market in UK: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.68 Veterinary Vaccines Market in Germany: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.69 Veterinary Vaccines Market in France: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.70 Veterinary Vaccines Market in Spain: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.71 Veterinary Vaccines Market in Italy: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.72 Veterinary Vaccines Market in Rest of Europe: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.73 Veterinary Vaccines Market in Asia-Pacific: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.74 Veterinary Vaccines Market in Australia: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.75 Veterinary Vaccines Market in China: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.76 Veterinary Vaccines Market in India: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.77 Veterinary Vaccines Market in Japan: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.78 Veterinary Vaccines Market in Philippines: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.79 Veterinary Vaccines Market in Rest of Asia-Pacific: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.80 Veterinary Vaccines Market in Latin America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.81 Veterinary Vaccines Market in Argentina: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.82 Veterinary Vaccines Market in Brazil: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.83 Veterinary Vaccines Market in Mexico: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.84 Veterinary Vaccines Market in Rest of Latin America: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.85 Veterinary Vaccines Market in Middle East and Africa: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.86 Veterinary Vaccines Market in Chad: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.87 Veterinary Vaccines Market in Ethiopia: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.88 Veterinary Vaccines Market in Nigeria: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Table 24.89 Veterinary Vaccines Market in Rest of Middle East and Africa: Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Billion)

Veterinary Vaccines Market